Navigation Links
Chem Rx Corporation Appoints Gary M. Jacobs Chief Financial Officer
Date:6/16/2008

LONG BEACH, N.Y., June 16 /PRNewswire-FirstCall/ -- Chem Rx Corporation (OTC Bulletin Board: CHRX, CHRXU, CHRXW), a leading provider of institutional pharmacy services, announced today the appointment of Gary M. Jacobs as the Company's Chief Financial Officer. Mr. Jacobs is an experienced finance professional with a background that includes corporate finance, SEC reporting and public accounting. Chem Rx also announced the resignation of its interim Chief Financial Officer, Joseph Sinicropi, effective immediately.

Jerry Silva, Chairman and Chief Executive Officer of Chem Rx Corporation, stated, "We are very pleased to welcome Gary Jacobs to the Chem Rx team. Gary's public company background, operations experience and understanding of financial markets will benefit our company as we continue our efforts to grow the business and implement new financial and accounting procedures and controls."

Mr. Jacobs remarked, "I look forward to joining the Chem Rx senior management team. My experience with implementing financial accounting systems and managing a public company's financial team will be valuable as I address my top priority of improving Chem Rx's financial controls."

Mr. Jacobs has over 30 years of experience in accounting, finance and operations. Since May 2005, he has been Chief Financial Officer and Chief Operating Officer of Karat Platinum LLC, which supplies and develops jewelry products. Karat Platinum LLC is a publicly held company, formerly known as Sentra Consulting Corp. Prior to that, Mr. Jacobs was President of The Innovative Companies, LLC, a supplier of natural stone; Executive Vice President of Operations and Corporate Secretary of The Hain Celestial Group, Inc., a publicly held food and personal care products company, where he also served as Executive Vice President of Finance, Chief Financial Officer and Treasurer prior to becoming Executive Vice President; Chief Financial Officer of Graham Field Health Products, Inc., a publicly held manufacturing and distribution company; and a member of the audit staff of Ernst & Young LLP, where he attained the position of senior manager. He is a certified public accountant and holds a Bachelor's of Business Administration in Accounting from Adelphi University.

About Chem Rx

Founded more than 40 years ago, Chem Rx is a major institutional pharmacy serving the New York City metropolitan area, as well as parts of New Jersey, upstate New York, Pennsylvania and Florida. Chem Rx's client base includes skilled nursing facilities and a wide range of other long-term care facilities. Chem Rx annually provides over six million prescriptions to more than 65,000 residents of more than 400 institutional facilities. Chem Rx's website address is http://www.chemrx.net.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about Chem Rx Corporation. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are based upon the current beliefs and expectations of Chem Rx's management and are subject to risks and uncertainties that could cause actual results to differ from the forward- looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: compliance with government regulations; changes in legislation or regulatory environments; requirements or changes adversely affecting the health care industry, including changes in Medicare reimbursement policies; fluctuations in customer demand; management of rapid growth; intensity of competition; timing, approval and market acceptance of new product introductions and institutional pharmacy locations; general economic conditions; geopolitical events and regulatory changes, as well as other relevant risks detailed in Chem Rx Corporation's filings with the SEC. The information set forth herein should be read in light of such risks. Chem Rx Corporation does not assume any obligation to update the information contained in this press release.

Contacts:

Steven C. Silva

President and Chief Operating Officer

Chem Rx Corporation

516-889-8770

Stephanie Carrington / Jared Hoffman

The Ruth Group

646-536-7017 / 7013

scarrington@theruthgroup.com

jhoffman@theruthgroup.com


'/>"/>
SOURCE Chem Rx Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Digirad Corporation to Present at CapStone Small-Cap Investor Conference
2. Insulet Corporation to Present at the William Blair & Company 28th Annual Growth Stock Conference on June 19, 2008
3. Harris Corporations Jim Traficant Addresses Florida Agency for Health Care Administration
4. Insulet Corporation Announces Pricing of $75 Million of Convertible Senior Notes
5. Linkwell Corporation Disinfection Epidemic Prevention Teams Enter into Sichuan Earthquake Area
6. Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes
7. ETHEX Corporation Voluntarily Recalls a Single Lot of Morphine Sulfate 60 mg Extended Release Tablets Due to the Potential for Oversized Tablets
8. Video: Zix Corporation Issues Statement Supporting Bipartisan Push for Medicare e-Prescribing Requirement
9. Baxa Corporation Named Finalist for Third Year as a Best Company to Work For in Colorado
10. Chemstar Corporation Publishes New Insights on Fresh Produce Safety From CFP Workshop
11. AGA Medical Corporation Agrees to Pay $2 Million Penalty and Enter Deferred Prosecution Agreement for FCPA Violations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... has received a new patent for its innovative Secure Messaging platform, which includes ... control. The new patent extends Cirius’s portfolio of patents around innovative features ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... wellness and sleep disorder management, today announced it has secured $9 million in ... (WiL) and existing investors. The investment will be used by Somnoware to further ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... announced today the introduction of the innovative newly improved Iso-Hip Wrap. The ... patients. The plush design enhances comfort and enables the patient to enjoy the ...
(Date:5/4/2016)... ... May 04, 2016 , ... a2z, Inc. ... Society™ and Canadian Association for Enterostomal Therapy (CAET) will be utilizing powerful and ... tools to attendees and exhibitors for the 2016 WOCN Society & CAET Joint ...
(Date:5/4/2016)... ... 04, 2016 , ... Washington Wellness Center today announced its tenth anniversary of ... What started out as an idea to provide a holistic approach to wellness has ... Developed by Dr. David Swanekamp, Chiropractic Physician , the wellness center offers a ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... DUBLIN , May 4, 2016 ... the "Global Cancer Stem Cell Therapy Market Outlook ... (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,Recombinant technology has ... therapeutics are expected to be developed in coming years. ... these techniques. Cancer stem cell therapies are also expected ...
(Date:5/3/2016)... , May 3, 2016  As a teenager, ... contracted rheumatic fever, which damaged his heart. He continued ... But by June 2013, Shepherd,s heart was giving out ... death. On June 20, 2013, the Mesa, ... Artificial Heart (TAH-t). Like a heart transplant, the SynCardia ...
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK , ... today announced Food and Drug Administration (FDA) approval ... that provides heart failure patients with access to ... also have remote monitoring with daily automatic transmission ... heart rate in response to physiological demands. ...
Breaking Medicine Technology: